DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) today announced completion of CE marking (market approval) in Europe for HOMECHOICE CLARIA, an automated peritoneal dialysis (APD ...

With one in four APD patients globally benefitting from Baxter’s two-way remote patient management technology, Sharesource offers patients and clinicians the ability to stay closely connected to ...

Baxter International Inc. BAX recently announced that it has received CE marking approval in Europe for HOMECHOICE CLARIA – its automated peritoneal dialysis (APD) system integrated with the ...

DEERFIELD, Ill., December 11, 2001 - Baxter Healthcare Corporation announced today it has received clearance from the U.S. Food and Drug Administration (FDA) to market its HomeChoice Pediatric ...

The Food & Drug Administration warns Baxter Healthcare Corp. about problems with its HomeChoice peritoneal dialysis systems after reports of patients developing peritonitis. The Food & Drug ...

Baxter International Inc. said it is recalling an in-home dialysis device that has been linked to serious injury reports and at least one death in the last two years. The U.S. Food and Drug ...

Baxter International Inc. BAX recently attained FDA approval for the Homechoice Claria automated peritoneal dialysis (APD) system with Sharesource connectivity platform. It is worth mentioning here ...

Global medical products and services company Baxter Healthcare Corp. says it has received clearance from the U.S. Food and Drug Administration to market its HomeChoice Pediatric automated peritoneal ...

Latest offering from global leader in automated peritoneal dialysis (APD) technology Cleared for adult and pediatric populations Available in 38 languages to support expanded ease of use for patients ...

Baxter International Inc. BAX recently attained FDA approval for the Homechoice Claria automated peritoneal dialysis (APD) system with Sharesource connectivity platform. It is worth mentioning here ...